Chlorhexidine Mouthwash Fails to Eradicate Oropharyngeal Gonorrhea in a Clinical Pilot Trial (MoNg)
- PMID: 34282741
- DOI: 10.1097/OLQ.0000000000001515
Chlorhexidine Mouthwash Fails to Eradicate Oropharyngeal Gonorrhea in a Clinical Pilot Trial (MoNg)
Abstract
This single-arm open-label pilot trial in Antwerp, Belgium, was ended early in accordance with the protocol because twice-daily gargling with chlorhexidine 0.2% for 6 days failed to eradicate Neisseria gonorrhoeae from the oropharynx of asymptomatic men who have sex with men (n = 3; efficacy of 0%; 95% confidence interval, 0%-56.1%).
Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.
Conflict of interest statement
Conflict of Interest and Sources of Funding: This trial was funded by an internal departmental grant. No conflicts of interest were declared.
References
-
- Miari VF, Ison CA. Is there a role for topical antiseptics in the treatment of gonorrhoea? Sex Transm Infect 2017; 93:79–80.
-
- Kong FYS, Horner P, Unemo M, et al. Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: A review. J Antimicrob Chemother 2019; 74:1157–1166.
-
- Kong FYS, Hatzis CL, Lau A, et al. Treatment efficacy for pharyngeal Neisseria gonorrhoeae : A systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2020; 75:3109–3119.
-
- Van Dijck C, Tsoumanis A, Rotsaert A, et al. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): A randomised, placebo-controlled, crossover trial. Lancet Infect Dis 2021; 21:657–667.
-
- Chow EPF, Maddaford K, Hocking JS, et al. An open-label, parallel-group, randomised controlled trial of antiseptic mouthwash versus antibiotics for oropharyngeal gonorrhoea treatment (OMEGA2). Sci Rep 2020; 10:1–7.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources